Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,632 Skin Cancer
clinical trials

Melanoma Clinical Trial
A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy (CheckMate 204)
Status: Enrolling, Phase II
Updated: 3/28/2016
mi
from
New Haven, CT
Click here to add this to my saved trials
Melanoma Clinical Trial
A Multi-Center Phase 2 Open-Label Study to Evaluate Safety and Efficacy in Subjects With Melanoma Metastatic to the Brain Treated With Nivolumab in Combination With Ipilimumab Followed by Nivolumab Monotherapy (CheckMate 204)
Status: Enrolling, Phase II
Updated: 3/28/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Denver, CO
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Long Beach, CA
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Morristown, NJ
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Portland, OR
Click here to add this to my saved trials
Advanced Cutaneous Melanoma Clinical Trial
A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma
Status: Enrolling
Updated: 3/29/2016
mi
from
Wichita, KS
Click here to add this to my saved trials
Melanoma Clinical Trial
Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells and Anti-CTLA4
Status: Enrolling, Phase II
Updated: 3/30/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
Status: Enrolling, Phase I, II
Updated: 3/30/2016
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Recurrent Clinical Trial
PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma
Status: Enrolling, Phase III
Updated: 3/30/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Acromegaly Clinical Trial
Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Status: Enrolling, Phase III
Updated: 3/31/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of Glembatumumab Vedotin in Patients With Advanced Melanoma
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Detroit, MI
Click here to add this to my saved trials
Melanoma Clinical Trial
A Study of Glembatumumab Vedotin in Patients With Advanced Melanoma
Status: Enrolling, Phase II
Updated: 4/1/2016
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Rochester, NY
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Bellflower, CA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Birmingham, AL
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Brewer, ME
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Charleston, WV
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Chillicothe, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Clive, IA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Columbus, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Decatur, IL
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Delaware, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Delaware, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Fargo, ND
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Findlay, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Iron Mountain, MI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Irvine, CA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Jefferson, IA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Kettering, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
La Crosse, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Lebanon, NH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Murray, UT
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
New Lenox, IL
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Oconto Falls, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Parkersburg, WV
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Pottsville, PA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Salina, KS
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
San Marcos, CA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Sturgeon Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Toledo, OH
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
West Des Moines, IA
Click here to add this to my saved trials
Oncology Clinical Trial
High-Dose Recombinant Interferon Alfa-2B or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery
Status: Enrolling, Phase III
Updated: 4/1/2016
mi
from
Wilson, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Billings, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Duluth, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Duluth, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Greenville, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Greer, SC
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Henderson, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Kalispell, MT
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Kingsport, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Lewes, DE
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Liberty, MO
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Maywood, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Moline, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Overland Park, KS
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Reed City, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Saint Joseph, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Saint Paul, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Cabozantinib-S-Malate Compared With Temozolomide or Dacarbazine in Treating Patients With Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 4/4/2016
mi
from
Vancouver, WA
Click here to add this to my saved trials
Unresectable Stage III or Stage IV Melanoma Clinical Trial
A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma
Status: Enrolling, Phase I, II
Updated: 4/5/2016
mi
from
St. Louis, MO
Click here to add this to my saved trials
Melanoma Clinical Trial
A Phase I/II Study of TPI 287 - Temozolomide Combination in Melanoma
Status: Enrolling, Phase I, II
Updated: 8/14/2015
mi
from
Houston, TX
Click here to add this to my saved trials
Melanoma Clinical Trial
Treatment With Dasatinib in Patients With Acral Lentiginous, Mucosal, or Chronic Sun-damaged Melanoma
Status: Enrolling
Updated: 7/16/2013
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Tremelimumab and CP-870,893 in Patients With Metastatic Melanoma
Status: Enrolling, Phase I
Updated: 2/25/2013
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Melanoma Clinical Trial
Using High Resolution Function Imaging To Detect Melanoma and Dysplastic Nevi
Status: Enrolling
Updated: 5/6/2010
mi
from
Baltimore, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Temozolomide or Selumetinib in Treating Patients With Metastatic Melanoma of the Eye
Status: Enrolling, Phase II
Updated: 12/6/2013
mi
from
Woodbury, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
Status: Enrolling
Updated: 7/13/2012
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Status: Enrolling
Updated: 7/26/2013
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Carboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell Cancer
Status: Enrolling, Phase II
Updated: 9/3/2015
mi
from
Philadephia, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma
Status: Enrolling, Phase II
Updated: 8/7/2015
mi
from
Nashville, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
Status: Enrolling
Updated: 6/11/2013
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ph II of Non-myeloablative Allogeneic Transplantation Using TLI & ATG In Patients w/ Cutaneous T Cell Lymphoma
Status: Enrolling, Phase II
Updated: 2/12/2014
mi
from
Stanford, CA
Click here to add this to my saved trials
Melanoma Clinical Trial
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
Status: Enrolling
Updated: 9/7/2012
mi
from
Houston, TX
Click here to add this to my saved trials
Oncology Clinical Trial
CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer
Status: Enrolling, Phase I, II
Updated: 4/3/2015
mi
from
Bethesda, MD
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Chicago, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Proviso, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy
Status: Enrolling
Updated: 10/21/2013
mi
from
Aurora, CO
Click here to add this to my saved trials
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 66